Etubics Enters Phase I Cancer Clinical Trials Focused On Colorectal CancerEtubics Corporation, a biopharmaceutical company developing "next generation" vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen (CEA)-expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S...
GE Launches Study To Improve Diagnosis Of Early Stage Colon CancerA team of scientists at GE Global Research, the technology development arm for the GE (NYSE: GE), has launched a study with Memorial Sloan-Kettering Cancer Center, (MSKCC) one of the world's premier cancer centers, to better understand the early stages of colon cancer. The goal is to yield new insights that improve treatment selection and outcomes for cancer patients in the future...
Researchers Block Stress Responses In Cancer Surgery Patients To Save LivesCancer surgery wreaks havoc on a body's immune system and stress hormones exacerbate the problem. As a result, about half of those who undergo surgery for tumor removal experience a recurrence of cancer in the same region or other parts of the body. A new clinical approach being developed and tested by Tel Aviv University researchers may be the key to making cancer operations more successful...
Cetuximab In Colon Cancer Therapy: New RecommendationsIn a report published in the July 2010 issue of the American Society for Clinical Oncology Post, new recommendations on the use of the drug cetuximab have been issued after officials halted enrollment in a phase III clinical trial in patients with spread of colon cancer into regional lymph nodes whose tumors had been surgically removed...
Spanish Study Analyzes The Probability Of Surviving Nine Types Of Cancer"The innovative factor contributed by our work is its relevance to population and measurement of relative survival, which enables us to discover survival related to cancer in a more precise way", MarÃÂa Dolores Chirlaque, main author of the study and researcher in the Epidemiology Service of the Department of Health and Consumption in Murcia, explains to SINC...